Latest news
Shubham Pant on KRAS Breakthroughs in Pancreatic Cancer Research - OncodailyOncodaily · Thu, 06 Aug 2026 21:32:58 GMTOlomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:38:44 GMTLilly's olomorasib earns FDA Breakthrough Therapy designation for KRAS G12C pancreatic cancer - AllSciAllSci · Mon, 03 Aug 2026 13:56:51 GMTLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - PR NewswirePR Newswire · Mon, 03 Aug 2026 11:45:00 GMT